These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 7996299)

  • 21. Treatment of Clostridium difficile-associated diarrhea and colitis.
    Gerding DN
    Curr Top Microbiol Immunol; 2000; 250():127-39. PubMed ID: 10981361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on Clostridium difficile-induced colitis, Part 2.
    Reinke CM; Messick CR
    Am J Hosp Pharm; 1994 Aug; 51(15):1892-901; quiz 1958-9. PubMed ID: 7942924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical manifestations, treatment and control of infections caused by Clostridium difficile.
    Bouza E; Muñoz P; Alonso R
    Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():57-64. PubMed ID: 15997485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial.
    Johnson S; Homann SR; Bettin KM; Quick JN; Clabots CR; Peterson LR; Gerding DN
    Ann Intern Med; 1992 Aug; 117(4):297-302. PubMed ID: 1322075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea.
    Hurley BW; Nguyen CC
    Arch Intern Med; 2002 Oct; 162(19):2177-84. PubMed ID: 12390059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Recurrent Clostridium difficile enterocolitis].
    Bergamin B; Hess T; Jost R; Ballmer PE; Imoberdorf R
    Schweiz Med Wochenschr; 2000 Nov; 130(44):1681-4. PubMed ID: 11103440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudomembranous colitis: causes and cures.
    Surawicz CM; McFarland LV
    Digestion; 1999; 60(2):91-100. PubMed ID: 10095149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis.
    Hassoun A; Ibrahim F
    Am J Geriatr Pharmacother; 2007 Mar; 5(1):48-51. PubMed ID: 17608247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.
    Johnson S
    J Infect; 2009 Jun; 58(6):403-10. PubMed ID: 19394704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clostridium difficile infections. Current aspects].
    Fulgione V
    Recenti Prog Med; 1998; 89(7-8):385-94. PubMed ID: 9691734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of antibiotic-associated pseudomembranous colitis.
    Gross MH
    Clin Pharm; 1985; 4(3):304-10. PubMed ID: 3891202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clostridium difficile associated diarrhea in the elderly patient].
    Pareja Sierra T; Hornillos Calvo M
    Rev Clin Esp; 2007 Feb; 207(2):86-90. PubMed ID: 17397570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clostridium difficile.
    Kyne L; Farrell RJ; Kelly CP
    Gastroenterol Clin North Am; 2001 Sep; 30(3):753-77, ix-x. PubMed ID: 11586556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clostridium difficile colitis.
    Efron PA; Mazuski JE
    Surg Clin North Am; 2009 Apr; 89(2):483-500, x. PubMed ID: 19281896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of antibiotic-associated colitis with vancomycin.
    Fekety R; Silva J; Buggy B; Deery HG
    J Antimicrob Chemother; 1984 Dec; 14 Suppl D():97-102. PubMed ID: 6520070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current and future treatment modalities for Clostridium difficile-associated disease.
    Halsey J
    Am J Health Syst Pharm; 2008 Apr; 65(8):705-15. PubMed ID: 18387898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy.
    Tieu JD; Schmidt SA; Miller JL; Kupiec KE; Skrepnek GH; Liu C; Smith WJ
    J Oncol Pharm Pract; 2019 Apr; 25(3):520-528. PubMed ID: 29157145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metronidazole may inhibit intestinal colonization with Clostridium difficile.
    Cleary RK; Grossmann R; Fernandez FB; Stull TS; Fowler JJ; Walters MR; Lampman RM
    Dis Colon Rectum; 1998 Apr; 41(4):464-7. PubMed ID: 9559631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with failure of metronidazole in Clostridium difficile-associated disease.
    Fernandez A; Anand G; Friedenberg F
    J Clin Gastroenterol; 2004; 38(5):414-8. PubMed ID: 15100520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.